We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma

This study has been withdrawn prior to enrollment.
(There were no patient enrolled in this study at this site)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00447356
First Posted: March 14, 2007
Last Update Posted: May 13, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Hackensack University Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: No date given
  Primary Completion Date: No date given